Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Up – What’s Next?

Bavarian Nordic (OTCMKTS:BVNRY)’s stock price gapped up before the market opened on Monday. The stock had previously closed at $11.48, but opened at $11.96. Bavarian Nordic shares last traded at $11.96, with a volume of 408 shares.

Bavarian Nordic Trading Down 1.5%

The company has a market capitalization of $2.80 billion, a P/E ratio of 12.08 and a beta of 1.25. The stock has a 50 day moving average price of $10.64 and a 200 day moving average price of $9.98.

Bavarian Nordic (OTCMKTS:BVNRY) last issued its quarterly earnings data on Friday, August 21st. The company reported $0.46 earnings per share for the quarter. The business had revenue of $316.47 million for the quarter. Bavarian Nordic had a return on equity of 11.97% and a net margin of 24.36%.

About Bavarian Nordic

Bavarian Nordic A/S is a Denmark-based biotechnology company focused on developing, manufacturing and commercializing vaccines. The company serves government agencies, healthcare providers, travelers and other customers through a portfolio of products addressing infectious diseases and public-health preparedness.

Its best-known vaccine is MVA-BN, marketed as Jynneos in the United States and Imvanex in the European Union, for protection against smallpox and mpox. Bavarian Nordic also markets vaccines for rabies, including Rabipur and RabAvert, and for tick-borne encephalitis under the Encepur brand.